Correlation Between Tube Investments and Beta Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tube Investments and Beta Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tube Investments and Beta Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tube Investments of and Beta Drugs, you can compare the effects of market volatilities on Tube Investments and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tube Investments with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tube Investments and Beta Drugs.

Diversification Opportunities for Tube Investments and Beta Drugs

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Tube and Beta is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Tube Investments of and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and Tube Investments is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tube Investments of are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of Tube Investments i.e., Tube Investments and Beta Drugs go up and down completely randomly.

Pair Corralation between Tube Investments and Beta Drugs

Assuming the 90 days trading horizon Tube Investments of is expected to under-perform the Beta Drugs. But the stock apears to be less risky and, when comparing its historical volatility, Tube Investments of is 1.58 times less risky than Beta Drugs. The stock trades about -0.16 of its potential returns per unit of risk. The Beta Drugs is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  196,500  in Beta Drugs on November 3, 2024 and sell it today you would lose (8,135) from holding Beta Drugs or give up 4.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tube Investments of  vs.  Beta Drugs

 Performance 
       Timeline  
Tube Investments 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tube Investments of has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Beta Drugs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Beta Drugs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Beta Drugs is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Tube Investments and Beta Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tube Investments and Beta Drugs

The main advantage of trading using opposite Tube Investments and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tube Investments position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.
The idea behind Tube Investments of and Beta Drugs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments